Spectranetics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Spectranetics and buy or sell other stocks, ETFs, and their options commission-free!

About SPNC

Spectranetics Corp. develops, manufactures, markets, and distributes single-use medical devices used in invasive procedures in the cardiovascular system. The company was founded by Robert Golobic, Johan Sverdrup, and Richard T. 

CEO
Scott William Drake
CEOScott William Drake
Employees
Employees
Headquarters
Colorado Springs, Colorado
HeadquartersColorado Springs, Colorado
Founded
1984
Founded1984
Employees
Employees

SPNC Key Statistics

Market cap
1.69B
Market cap1.69B
Price-Earnings ratio
-24.18
Price-Earnings ratio-24.18
Dividend yield
Dividend yield
Average volume
752.63K
Average volume752.63K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$38.55
52 Week high$38.55
52 Week low
$19.80
52 Week low$19.80

Stock Snapshot

As of today, Spectranetics(SPNC) shares are valued at $38.45. The company's market cap stands at 1.69B, with a P/E ratio of -24.18.

On 2026-04-02, Spectranetics(SPNC) stock opened at —, reached a high of —, and a low of —.

Spectranetics(SPNC) shares are trading with a volume of 0, against a daily average of 752.63K.

During the past year, Spectranetics(SPNC) stock moved between $19.80 at its lowest and $38.55 at its peak.

During the past year, Spectranetics(SPNC) stock moved between $19.80 at its lowest and $38.55 at its peak.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.